ClinicalTrials.gg

Program

DC-806

A development code.

Its studies are mostly in Psoriasis, led by Eli Lilly.

Furthest: phase 2, since May 31, 20235 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Eli Lilly50 open or runningphase 2since May 31, 2023May 31, 2023none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. May 31, 2023First study: phase 2 study in Plaque PsoriasisFirst studyNCT05896527 · 229 enrolled · United States, Canada, Czechia and more
  2. Aug 9, 2023Phase 1 study in Healthy VolunteersNCT05994807 · 33 enrolled · United States
  3. Sep 13, 2023Phase 1 study in Healthy VolunteersNCT06045000 · 8 enrolled · Netherlands
  4. Oct 16, 2023Phase 1 study in Healthy ParticipantsNCT06092931 · 28 enrolled · United States
  5. Jan 31, 2025Phase 1 study in Plaque PsoriasisNCT06808815 · 104 enrolled · United Kingdom

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06808815Plaque Psoriasis · United Kingdom1CompletedAug 23, 2022104
NCT06092931Healthy Participants · United States1CompletedNov 28, 202328
NCT06045000Healthy Volunteers · Netherlands1CompletedOct 2, 20238
NCT05994807Healthy Volunteers · United States1CompletedSep 20, 202333
NCT05896527Plaque Psoriasis · United States, Canada, Czechia and more2CompletedMar 25, 2024229

How it is read

Names in the registry

  • “DC-806”, 5 entries

Codes read as this program: DC806.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.